Rare cancers: Challenges & issues
نویسندگان
چکیده
منابع مشابه
Rare Cancers: Challenges for Cancer Prevention and Treatment
Recently a workshop was held on Rare Cancers to discuss the issues and challenges associated with rare cancers and to facilitate collaborations among the participants. Approximately 200 participants including scientists, clinicians, industry, government, and patient advocates met for the workshop. The day and a half workshop was structured with plenary sessions for the first half-day followed b...
متن کاملSandwich Generation Issues and Challenges
Today, with the increase in the elderly population and life expectancy, the need to use care services for this significant part of the population is increasing. Beliefs, cultures, and social norms among different ethnicities and races are vital in the extent and nature of care. Two types of care exist, informal and formal. According to statistics by the Secretariat of the National Council on Ag...
متن کاملIdentifying specific social challenges of rare diseases: current challenges and issues
Background EURORDIS Care Survey program conducted with over 12000 patients in 23 countries (2002-2008) has concluded that «social security systems are usually designed around common diseases and are not flexible enough to take into consideration unprecedented health needs» [1] and has provided a few insights into rare diseases (RD) patients and families social challenges. Further data collectio...
متن کاملInternational Rare Cancers Initiative (IRCI)
There is no internationally agreed definition of a rare cancer. In Europe, rare diseases are often defined as those with a prevalence of <50/100,000 [1]. In the US, the Orphan Drug Designation Program defines rare diseases as those affecting <200,000 people in the total US population, equivalent to a prevalence of 64/100,000 [1]. The problem with both these definitions is that they are based on...
متن کاملNovel approaches to improve the treatment of rare gynecologic cancers: research opportunities and challenges.
More than 50% of all gynecologic cancers can be classified as rare tumors (defined as an incidence of fewer than six per 100,000). Improved understanding of the molecular pathogenesis of tumors increases the proportion of rare tumors and creates challenges in optimizing the design of clinical trials. Novel trial designs are needed to take forward the development of new treatments in rare tumors...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Medical Research
سال: 2017
ISSN: 0971-5916
DOI: 10.4103/ijmr.ijmr_915_14